Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 20:13:24 EDT

Explore

PostsPeople
LatestRanked
@edgarvlermamd.medsky.networkOct 11, 2026, 2:22 AM

Approach to hematuria ca. 2026 from @ajkd.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42767705/

@edgarvlermamd.medsky.networkOct 10, 2026, 12:25 PM

PRO/CON debate: nonsteroidal (finerenone) vs. steroidal (spironolactone/ eplerenone) mineralocorticoid receptor antagonists in CKD: progress, pragmatism, and remaining uncertainties ca. 2026 from @ckj-era.bsky.social
#Nephpearls #Cardiorenal #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42682722/

@edgarvlermamd.medsky.networkOct 7, 2026, 12:53 PM

C3G Glomerulopathy: Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org
#Nephpearls #NephSky

👉 kdigo.org/infographics/

@edgarvlermamd.medsky.networkOct 7, 2026, 12:41 PM

IgA Nephropathy #IgAN: Pathophysiology and Mechanistic Targets 🎯 of Potential Novel Therapies from @kdigo.org
#Nephpearls #NephSky

👉 kdigo.org/infographics/

@edgarvlermamd.medsky.networkOct 4, 2026, 5:58 PM

Select RCTs, informing current management strategies for patients with SA-AKI
#Nephpearls #AKIinICU #NephJC #NephSky

👉 shop.lww.com/Handbook-of-...

@edgarvlermamd.medsky.networkOct 4, 2026, 5:21 PM

Sepsis-associated AKI (SA-AKI): Pathophysiology
#Nephpearls #AKIinICU

📌 Organ dysfunction during sepsis develops even in the absence of decreased O2 delivery (Hypotension and ischemic injury are not the sole cause)

👉 pubmed.ncbi.nlm.nih.gov/36823168/

@edgarvlermamd.medsky.networkOct 4, 2026, 4:52 PM

Sepsis is a syndrome defined by organ dysfunction because of a dysregulated host response to infection
#Nephpearls #AKIinICU #NephSky

📌 Septic shock is a subset of sepsis defined by hypotension requiring vasopressors to maintain an MAP >/= 65 mm Hg and serum lactate >2 mmol/L after resuscitation

@edgarvlermamd.medsky.networkOct 3, 2026, 12:38 AM

Treatment with maximally tolerated RAASi alone does not sufficiently slow the rate of eGFR decline in high-risk patients with IgA nephropathy #IgAN, leaving patients at risk of ESKD ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/42584957/

@edgarvlermamd.medsky.networkSep 30, 2026, 11:03 PM

Clinical conditions related to LVADs that may arise during hemodialysis
#Nephpearls #NephSky

👉 link.springer.com/book/10.1007...

@edgarvlermamd.medsky.networkSep 30, 2026, 10:44 PM

Call 📢 for papers: "The Jerry Yee: Clinical Challenges in Diagnosis and Treatment in Nephrology"
#Nephpearls #NephSky

🗓️ Deadline for submissions: 15 October 2026

👉 www.sciencedirect.com/special-issu...

@edgarvlermamd.medsky.networkSep 30, 2026, 9:07 AM

Impact of proteinuria levels on long-term kidney outcomes in IgA nephropathy: a meta-analysis ca. 2026 from @glomcon.org Rare Kidney Disease journal
#Nephpearls #NephSky

👉🏼 link.springer.com/article/10.1...

@edgarvlermamd.medsky.networkSep 30, 2026, 8:40 AM

Ten tips for the diagnosis and management of nephrotic syndrome ca. 2026
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/42707999/

@edgarvlermamd.medsky.networkSep 26, 2026, 9:59 PM

Classic course of whole-kidney GFR and UAE according to the natural (proteinuric) pathway of #Diabetic #Kidney Disease (DKD) ca. 2017
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/28143897/

@edgarvlermamd.medsky.networkSep 26, 2026, 6:54 PM

Adults with #IgAN are at greater risk of adverse kidney outcomes versus nonglomerular CKD and substantially higher risks of heart failure and death compared with no CKD ca. 2026 from @KIReports
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/42027552/

@edgarvlermamd.medsky.networkSep 26, 2026, 6:43 PM

Not all #IgAN therapies are created equal
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/40928891/

@edgarvlermamd.medsky.networkSep 26, 2026, 6:28 PM

Dipstick hemoglobinuria is associated with histologic markers of active disease in #IgAN and may provide clinically relevant information to complement current assessment of disease activity in #IgAN ca. 2026
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/42628835/

@edgarvlermamd.medsky.networkSep 26, 2026, 6:20 PM

Microscopic hematuria as a risk factor for #IgAN progression: considering this biomarker in selecting and monitoring patients ca. 2023
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38053974/

@edgarvlermamd.medsky.networkSep 26, 2026, 5:13 PM

Targeting B cells in immune-mediated kidney diseases: conclusions from @kdigo.org Controversies Conference ca. 2026
#Nephpearls #RKDSummit #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/42034308/

@edgarvlermamd.medsky.networkSep 25, 2026, 3:52 AM

Colloids vs Crystalloids
#Nephpearls #AKIinICU #NephSky

👉 shop.lww.com/Handbook-of-...

@edgarvlermamd.medsky.networkSep 5, 2026, 4:38 PM

Kidney Health Guidance on Cardiovascular-Kidney-Metabolic (CKM) Syndrome ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky #Cardiorenal

👉 pubmed.ncbi.nlm.nih.gov/42684397/